Valneva Commences Rolling Submission to MHRA for its COVID-19 Vaccine
Valneva SE commenced rolling submission, for initial approval of its COVID-19 vaccine candidate, VLA2001, with the Medicines and Healthcare products Regulatory Agency (MHRA) in the United Kingdom (UK). VLA2001 is a whole virus, inactivated, adjuvanted [...]